Topic: Takeda Pharmaceutical Co. Ltd.

Takeda to cut about 150 local jobs

Crain's: Chicago - 16 days ago
Tweet Print | Email | abilitation Institute's new hospital to have 50% more beds Baxter suing insurer to recoup millions in bad blood settlements...

UK Regulator Gives Takeda Bone Cancer Drug Final Backing

FOX Business - 108 days ago
Takeda Pharmaceutical Co.'s (4502. TO) drug mifamurtide has secured final backing from the U.K.'s health-care cost-effectiveness regulator for use...

Furiex Confirms Takeda Launches LIOVEL LD and LIOVEL HD, a Fixed Dose Combination of NESINA and ACTOS, for Type 2 Diabetes in Japan

Benzinga.com - 143 days ago
Posted on 09/20/11 at 1:31pm by Eddie Staley . Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) today confirmed that Takeda Pharmaceutical Company...

Affymax Receives $10M Milestone Payment for FDA Filing of New Drug Application for Hematide/Peginesatide

Benzinga.com - 185 days ago
Posted on 08/10/11 at 8:08am by Eddie Staley . Affymax, Inc. (Nasdaq: AFFY ) today announced that it has received a $10 million development...

Amylin, Takeda Stop Development of Obesity Treatment

Benzinga.com - 190 days ago
Posted on 08/04/11 at 9:21pm by Greg Chalmers . Amylin Pharmaceuticals (NASDAQ: AMLN ) and Takeda Pharmaceutical (OTC: TKPYY) today announced that...

Takeda Pharmaceutical 1Q Group Net Profit Y75.58 Billion, Up 18% On Year

FOX Business - 197 days ago
Takeda Pharmaceutical Co. (4502. TO) said Friday that its net profit for the three months through June gained 18% as sales of relatively new drugs...

Takeda Cambridge in Second Deal to Expand Use of Dimerix's GPCR-HIT Platform

American Banking News - 304 days ago
Takeda Cambridge in Second Deal to Expand Use of Dimerix's GPCR-HIT Platform. . Apr. 13, 2011 (Business Wire) - Dimerix Bioscience Pty Ltd today...

Florida Hospital, Sanford-Burnham Medical Research Institute and Takeda Announce Partnership to Target Obesity

American Banking News - 410 days ago
Florida Hospital, Sanford-Burnham Medical Research Institute and Takeda Announce Partnership to Target Obesity. . Florida Hospital, Sanford-Burnham...

A.M. Vitals: U.S. Appeals Court Hears Stem Cell Arguments

Wall Street Journal Health Blog - 501 days ago
Stem Cell Debate: A U.S. appeals court heard oral arguments yesterday on whether a judge's ruling barring federal funding of embryonic stem-cell research should be temporarily lifted as the case wends its way through the court system, Dow Jones Newswires ...

Orexigen Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave in North America

Drugs.com - 526 days ago
Orexigen Therapeutics, Inc. (NASDAQ:OREX) and Takeda Pharmaceutical Company Limited , today announced that they have entered into an exclusive partnership to develop and commercialize Contrave (naltrexone SR/bupropion SR), Orexigen's investigational drug for the treatment of obesity, in the United States ...